Quantum BioPharma Ltd.
Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments. The company researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in d… Read more
Market Cap & Net Worth: Quantum BioPharma Ltd. (QNTM)
Quantum BioPharma Ltd. (NASDAQ:QNTM) has a market capitalization of $9.20 Million ($9.20 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29210 globally and #9692 in its home market, demonstrating a -28.72% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Quantum BioPharma Ltd.'s stock price $2.40 by its total outstanding shares 3842935 (3.84 Million).
Quantum BioPharma Ltd. Market Cap History: 2018 to 2026
Quantum BioPharma Ltd.'s market capitalization history from 2018 to 2026. Data shows change from $10.74 Billion to $9.20 Million (-54.65% CAGR).
Index Memberships
Quantum BioPharma Ltd. is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.00% | #756 of 976 |
Weight: Quantum BioPharma Ltd.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Quantum BioPharma Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Quantum BioPharma Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of QNTM by Market Capitalization
Companies near Quantum BioPharma Ltd. in the global market cap rankings as of March 18, 2026.
Key companies related to Quantum BioPharma Ltd. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Quantum BioPharma Ltd. Historical Marketcap From 2018 to 2026
Between 2018 and today, Quantum BioPharma Ltd.'s market cap moved from $10.74 Billion to $ 9.20 Million, with a yearly change of -54.65%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $9.20 Million | -67.19% |
| 2025 | $28.05 Million | +98.37% |
| 2024 | $14.14 Million | -93.85% |
| 2023 | $229.81 Million | +16.75% |
| 2022 | $196.84 Million | -22.75% |
| 2021 | $254.79 Million | -34.62% |
| 2020 | $389.67 Million | -71.27% |
| 2019 | $1.36 Billion | -87.38% |
| 2018 | $10.74 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Quantum BioPharma Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.20 Million USD |
| MoneyControl | $9.20 Million USD |
| MarketWatch | $9.20 Million USD |
| marketcap.company | $9.20 Million USD |
| Reuters | $9.20 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.